# AMLODIPINE AND OLMESARTAN MEDOXOMIL
> **ANDA209010** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2018-12-03
## Drug
- **FDA Application Number:** ANDA209010
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE AND OLMESARTAN MEDOXOMIL
- **Generic name:** AMLODIPINE AND OLMESARTAN MEDOXOMIL
- **Active ingredients:** AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals, Inc
- **First approval:** 2018-12-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209010)
---
*MORVS · CC0 1.0*